https://uat-bioconbiologics-ca.bioconbiologicsit.com/biocon-biologics-yesafili-aflibercept-now-publicly-funded-in-ontario-canada-for-the-advanced-treatment-of-patients-with-retinal-diseases/ 2025-10-13T11:00:43+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/biocon-biologics-receives-health-canada-approval-for-yesintek-and-yesintek-i-v-ustekinumab-a-biosimilar-to-stelara/ 2025-10-27T12:38:55+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/fr/yesintek/ 2026-04-06T08:01:16+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/wp-content/uploads/2025/11/yesintek_logo-FR.png https://uat-bioconbiologics-ca.bioconbiologicsit.com/wp-content/uploads/2025/04/Group-1049-2.png https://uat-bioconbiologics-ca.bioconbiologicsit.com/wp-content/uploads/2025/04/Group-1049-2.png https://uat-bioconbiologics-ca.bioconbiologicsit.com/fr/biocon-biologics-recoit-lapprobation-de-sante-canada-pour-yesintekmc-et-yesintekmc-i-v-ustekinumab-un-biosimilaire-a-stelaramd/ 2026-04-08T09:19:03+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/biocon-biologics-and-viatris-launch-abevmy-bbevacizumab-their-third-oncology-biosimilar-in-canada-biocon-biologics/ 2026-04-15T11:28:54+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/biocon-and-mylan-launch-fulphila-biosimilar-pegfilgrastim-in-canada-biocon-biologics/ 2026-04-15T11:31:01+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/biocon-biologics-secures-canada-market-entry-date-for-yesafili-a-proposed-biosimilar-to-eylea-biocon-biologics/ 2026-04-15T11:33:04+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/fr/biocon-biologics-fixe-une-date-dentree-sur-le-marche-canadien-pour-yesafilimd-un-biosimilaire-propose-de-eylea-biocon-biologics/ 2026-04-15T11:35:49+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/fr/biocon-biologics-et-viatris-lancent-abevmymd-bevacizumab-leur-troisieme-biosimilaire-en-oncologie-au-canada-biocon-biologics/ 2026-04-15T11:57:44+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/fr/biocon-et-mylan-lancent-fulphilamd-un-biosimilaire-de-pegfilgrastim-au-canada/ 2026-04-15T12:39:25+00:00 https://uat-bioconbiologics-ca.bioconbiologicsit.com/fr/yesafili-aflibercept-de-biocon-biologics-est-maintenant-rembourse-par-le-regime-public-de-lontario-canada-pour-le-traitement-avance-des-patients-atteints-de-maladies-retiniennes/ 2026-04-15T12:39:51+00:00